Optimizing Early-Stage NSCLC Management: A Multidisciplinary Perspective - Episode 2
Optimizing Tissue Biopsy and Disease Staging in Early-Stage NSCLC
Panelists discuss how medical professionals frequently encounter tissue adequacy challenges in comprehensive genomic profiling for early-stage non–small cell lung cancer (NSCLC), employing strategies such as optimized biopsy techniques, efficient tissue triage protocols, and complementary liquid biopsies to ensure sufficient material for complete molecular analysis.
Video content above is prompted by the following:
Tissue Adequacy Challenges in Comprehensive Genomic Profiling for Early-Stage NSCLC
Prevalence of Tissue Adequacy Challenges
Medical professionals frequently encounter tissue adequacy issues when performing comprehensive genomic profiling (CGP) in early-stage NSCLC. Insufficient tissue quantity and quality represent significant barriers to complete molecular assessment, potentially compromising therapeutic decision-making.
Current Mitigation Strategies
Clinicians employ several approaches to address tissue limitations:
- Prioritizing molecular testing over routine diagnostics when tissue is limited
- Implementing RNA-based fusion panels to maximize information from minimal specimens
- Using reflex testing algorithms to conserve tissue
- Coordinating multidisciplinary discussions between pathologists, pulmonologists, and oncologists
Optimization of Biopsy Techniques
To improve tissue, yield and adequacy:
- Utilize rapid on-site evaluation during procedures to confirm sample adequacy
- Consider core needle biopsies over fine needle aspiration when feasible
- Employ navigational bronchoscopy techniques for peripheral lesions
- Implement standardized collection protocols specifically designed for molecular testing
- Optimize tissue processing methods to preserve nucleic acid integrity
Tissue Triage Best Practices
Effective tissue management includes:
- Establishing clear institutional protocols for specimen handling
- Sectioning specimens efficiently to minimize waste
- Prioritizing molecular testing based on clinical relevance
- Using multiplexed assays that require less input material
- Storing additional slides for potential future testing needs
Role of Liquid Biopsies
Liquid biopsies are emerging as complementary or alternative options:
- May serve as a rescue strategy when tissue is inadequate
- Provide noninvasive monitoring capabilities during treatment
- Allow for serial sampling to track molecular evolution
- Potentially detect molecular alterations missed in heterogeneous tumors
- Currently limited in early-stage disease due to lower circulating tumor DNA concentrations
Related Content:
